128 related articles for article (PubMed ID: 32218803)
1. PREPL Deficiency: A Homozygous Splice Site PREPL Mutation in a Patient With Congenital Myasthenic Syndrome and Absence of Ovaries and Hypoplasia of Uterus.
Yang Q; Hua R; Qian J; Yi S; Shen F; Zhang Q; Li M; Yi S; Luo J; Fan X
Front Genet; 2020; 11():198. PubMed ID: 32218803
[TBL] [Abstract][Full Text] [Related]
2. The second point mutation in PREPL: a case report and literature review.
Silva S; Miyake N; Tapia C; Matsumoto N
J Hum Genet; 2018 May; 63(5):677-681. PubMed ID: 29483676
[TBL] [Abstract][Full Text] [Related]
3. First maternal uniparental disomy for chromosome 2 with PREPL novel frameshift mutation of congenital myasthenic syndrome 22 in an infant.
Zhang P; Wu B; Lu Y; Ni Q; Liu R; Zhou W; Wang H
Mol Genet Genomic Med; 2020 Mar; 8(3):e1144. PubMed ID: 31985178
[TBL] [Abstract][Full Text] [Related]
4. Prolyl Endopeptidase-like Deficiency Associated with Growth Hormone Deficiency.
Sayol-Torres L; Valenzuela MI; Tomasini R; Fernández-Alvarez P; Clemente M; Yeste D
J Clin Res Pediatr Endocrinol; 2023 May; 15(2):205-209. PubMed ID: 34693706
[TBL] [Abstract][Full Text] [Related]
5. PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.
Régal L; Shen XM; Selcen D; Verhille C; Meulemans S; Creemers JW; Engel AG
Neurology; 2014 Apr; 82(14):1254-60. PubMed ID: 24610330
[TBL] [Abstract][Full Text] [Related]
6. PREPL deficiency: delineation of the phenotype and development of a functional blood assay.
Régal L; Mårtensson E; Maystadt I; Voermans N; Lederer D; Burlina A; Juan Fita MJ; Hoogeboom AJM; Olsson Engman M; Hollemans T; Schouten M; Meulemans S; Jonson T; François I; Gil Ortega D; Kamsteeg EJ; Creemers JWM
Genet Med; 2018 Jan; 20(1):109-118. PubMed ID: 28726805
[TBL] [Abstract][Full Text] [Related]
7. PREPL, a prolyl endopeptidase-like enzyme by name only?--Lessons from patients.
Boonen K; Régal L; Jaeken J; Creemers JW
CNS Neurol Disord Drug Targets; 2011 May; 10(3):355-60. PubMed ID: 21222627
[TBL] [Abstract][Full Text] [Related]
8. Similar metabolic pathways are affected in both Congenital Myasthenic Syndrome-22 and Prader-Willi Syndrome.
Bhalla K; Rosier K; Monnens Y; Meulemans S; Vervoort E; Thorrez L; Agostinis P; Meier DT; Rochtus A; Resnick JL; Creemers JWM
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167175. PubMed ID: 38626828
[TBL] [Abstract][Full Text] [Related]
9. Prolyl endopeptidase-like is a (thio)esterase involved in mitochondrial respiratory chain function.
Rosier K; McDevitt MT; Smet J; Floyd BJ; Verschoore M; Marcaida MJ; Bingman CA; Lemmens I; Dal Peraro M; Tavernier J; Cravatt BF; Gounko NV; Vints K; Monnens Y; Bhalla K; Aerts L; Rashan EH; Vanlander AV; Van Coster R; Régal L; Pagliarini DJ; Creemers JWM
iScience; 2021 Dec; 24(12):103460. PubMed ID: 34888501
[TBL] [Abstract][Full Text] [Related]
10. A Family Case of Congenital Myasthenic Syndrome-22 Induced by Different Combinations of Molecular Causes in Siblings.
Shchagina O; Bessonova L; Bychkov I; Beskorovainaya T; Poliakov A
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32707643
[TBL] [Abstract][Full Text] [Related]
11. Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome.
Jaeken J; Martens K; Francois I; Eyskens F; Lecointre C; Derua R; Meulemans S; Slootstra JW; Waelkens E; de Zegher F; Creemers JW; Matthijs G
Am J Hum Genet; 2006 Jan; 78(1):38-51. PubMed ID: 16385448
[TBL] [Abstract][Full Text] [Related]
12. Deletion of PREPl causes growth impairment and hypotonia in mice.
Lone AM; Leidl M; McFedries AK; Horner JW; Creemers J; Saghatelian A
PLoS One; 2014; 9(2):e89160. PubMed ID: 24586561
[TBL] [Abstract][Full Text] [Related]
13. Cellular and ultra structural evidence for cytoskeletal localization of prolyl endopeptidase-like protein in neurons.
Morawski M; Nuytens K; Juhasz T; Zeitschel U; Seeger G; Waelkens E; Regal L; Schulz I; Arendt T; Szeltner Z; Creemers J; Rossner S
Neuroscience; 2013 Jul; 242():128-39. PubMed ID: 23485813
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
[TBL] [Abstract][Full Text] [Related]
15. Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome.
Chabrol B; Martens K; Meulemans S; Cano A; Jaeken J; Matthijs G; Creemers JW
J Med Genet; 2008 May; 45(5):314-8. PubMed ID: 18234729
[TBL] [Abstract][Full Text] [Related]
16. Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome.
Chabrol B; Martens K; Meulemans S; Cano A; Jaeken J; Matthijs G; Creemers JW
BMJ Case Rep; 2009; 2009():. PubMed ID: 21686663
[TBL] [Abstract][Full Text] [Related]
17. A substrate-free activity-based protein profiling screen for the discovery of selective PREPL inhibitors.
Lone AM; Bachovchin DA; Westwood DB; Speers AE; Spicer TP; Fernandez-Vega V; Chase P; Hodder PS; Rosen H; Cravatt BF; Saghatelian A
J Am Chem Soc; 2011 Aug; 133(30):11665-74. PubMed ID: 21692504
[TBL] [Abstract][Full Text] [Related]
18. A synonymous CHRNE mutation responsible for an aberrant splicing leading to congenital myasthenic syndrome.
Richard P; Gaudon K; Fournier E; Jackson C; Bauché S; Haddad H; Koenig J; Echenne B; Hantaï D; Eymard B
Neuromuscul Disord; 2007 May; 17(5):409-14. PubMed ID: 17363247
[TBL] [Abstract][Full Text] [Related]
19. Clinical Application of Whole Exome Sequencing to Identify Rare but Remediable Neurologic Disorders.
Kim MJ; Yum MS; Seo GH; Lee Y; Jang HN; Ko TS; Lee BH
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33233562
[TBL] [Abstract][Full Text] [Related]
20. A Splice Site Mutation Associated with Congenital CD59 Deficiency.
Chai JN; Azad AK; Kuan K; Guo X; Wang Y
Hematol Rep; 2022 May; 14(2):172-178. PubMed ID: 35735736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
